Detalles de la búsqueda
1.
Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis.
J Pharmacol Exp Ther
; 369(3): 481-488, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30971477
2.
Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain.
Nanomedicine
; 16: 258-266, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30300748
3.
Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane.
Neurobiol Dis
; 114: 1-16, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29477640
4.
Unique molecular signatures of Alzheimer's disease amyloid ß peptide mutations and deletion during aggregate/oligomer/fibril formation.
J Neurosci Res
; 93(3): 410-23, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25377128
5.
Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-ß proteins in the cerebral vasculature.
Mol Pharm
; 10(5): 1557-65, 2013 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23249146
6.
Alzheimer's disease amyloid ß-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Biochemistry
; 51(19): 3993-4003, 2012 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22545812
7.
Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery.
Mol Pharm
; 9(7): 1887-97, 2012 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22574751
8.
Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein.
Nanomedicine
; 8(2): 250-60, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21704598
9.
Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-ß Peptides and Insulin.
J Alzheimers Dis
; 85(3): 1031-1044, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34924382
10.
Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies.
Biochemistry
; 48(43): 10405-15, 2009 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-19775170
11.
Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease.
Magn Reson Med
; 61(5): 1158-64, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19253386
12.
Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice.
Neurochem Res
; 34(1): 102-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18373196
13.
Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.
J Cereb Blood Flow Metab
; 38(5): 904-918, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28569090
14.
Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Neuroscientist
; 13(1): 38-48, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17229974
15.
In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice.
J Neurosci
; 25(43): 10041-8, 2005 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-16251453
16.
Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Brain Res
; 1045(1-2): 185-98, 2005 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-15910777
17.
Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model.
Brain Res
; 1027(1-2): 73-86, 2004 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-15494159
18.
Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain.
Biomaterials
; 35(6): 1967-76, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24331706
19.
Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits.
J Control Release
; 185: 121-9, 2014 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24735640
20.
Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease.
PLoS One
; 7(2): e32737, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22393443